BVS
Bioventus Inc
NASDAQ: BVS · HEALTHCARE · MEDICAL DEVICES
$9.87
+2.07% today
Updated 2026-04-30
Market cap
$682.47M
P/E ratio
30.58
P/S ratio
1.20x
EPS (TTM)
$0.33
Dividend yield
—
52W range
$6 – $11
Volume
0.4M
Bioventus Inc (BVS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
4.00%
Operating margin
13.80%
ROE
13.20%
ROA
4.99%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $232.38M | $-22.37M | 69.29% | -3.47% | -9.63% |
| 2014 | $242.89M | $-12.90M | 69.28% | 0.01% | -5.31% |
| 2015 | $253.65M | $-34.11M | 70.69% | -6.54% | -13.45% |
| 2016 | $274.50M | $-17.95M | 66.71% | 5.42% | -6.54% |
| 2017 | $292.06M | $-1.64M | 68.47% | 9.25% | -0.56% |
| 2018 | $319.18M | $-12.21M | 73.63% | 7.99% | -3.82% |
| 2019 | $340.14M | $6.85M | 73.27% | 9.17% | 2.01% |
| 2020 | $321.16M | $16.41M | 72.71% | 6.61% | 5.11% |
| 2021 | $430.90M | $19.38M | 70.25% | 2.80% | 4.50% |
| 2022 | $512.12M | $-158.70M | 64.65% | -32.66% | -30.99% |
| 2023 | $512.35M | $-156.23M | 64.06% | -15.95% | -30.49% |
| 2024 | $573.28M | $-33.54M | 67.72% | -2.09% | -5.85% |
| 2025 | $568.09M | $22.73M | 67.32% | 10.31% | 4.00% |